Guilingan, Aicel .
HRN: 27-98-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2025
CEFUROXIME 500MG (TAB)
10/23/2025
10/29/2025
PO
500mg Tab
1 Tab BID X 7 Days
S/p Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes